Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00434525 · ClinicalTrials.gov registry record · Phase 3
Laparoscopic Sleeve Gastrectomy With and Without Omentectomy
A Phase 3 study of Morbid Obesity, sponsored by North Texas Veterans Healthcare System.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00434525: Completed Phase 3 study of Morbid Obesity, sponsored by North Texas Veterans Healthcare System.
NCT00434525 is a Phase 3 study of Morbid Obesity that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 30 participants, below the 121-participant average among 24 other Morbid Obesity trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00434525, a Phase 3 study of Morbid Obesity, has completed, sponsored by North Texas Veterans Healthcare System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
* The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity. * The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by sleeve gastrectomy and omentectomy (omentum or intra-abdominal fat removal) will provide clinical and metabolic benefits for morbidly obese patients.
Conditions Studied
Interventions
- PROCEDURE Laparoscopic restrictive procedure
- PROCEDURE Sleeve gastrectomy
Study Locations (1)
Texas
- VA North Texas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-12 |
| Phase | Phase 3 |
What the finished NCT00434525 record still lists
NCT00434525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 121-participant average among 24 other Morbid Obesity trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 2 interventions - of which Laparoscopic restrictive procedure is the first listed.
NCT00434525 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00434525 about?
NCT00434525 is a clinical study titled "Laparoscopic Sleeve Gastrectomy With and Without Omentectomy". * The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity. * The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by slee...
What is the current status of trial NCT00434525?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2008-01. Estimated completion is 2009-12.
What conditions does trial NCT00434525 study?
This clinical trial studies the following conditions: Morbid Obesity.
What interventions are being tested in trial NCT00434525?
The interventions under investigation include: Laparoscopic restrictive procedure (PROCEDURE), Sleeve gastrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00434525?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00434525 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00434525's enrollment target sits among peer trials
30 23rd of 24 higher than 2 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Induction of Labor in Morbidly Obese Patients
RECRUITING · Early Phase 1
-
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
RECRUITING
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Gut Microbiota in Metabolic Surgery
RECRUITING
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Metabolic Responses to Bariatric Surgery
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia